Cannabinoids and similars

Name
Cannabinoids and similars
Accession Number
DBCAT002709  (DBCAT000906, DBCAT000907)
Description

Compounds having the cannabinoid function.

ATC Classification
Drugs
DrugDrug Description
DronabinolA synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy.
NabiloneA synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy.
RimonabantFor use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m2, or patients wih a BMI greater than 27 kg/m2 with associated...
CannabidiolAn active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer.
Ajulemic acidAjulemic acid has been used in trials studying the treatment of Cystic Fibrosis, Dermatomyositis, and Diffuse Cutaneous Systemic Sclerosis.
IbipinabantIbipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.
SurinabantSurinabant has been investigated for the treatment of Smoking Cessation.
WIN 55212-2WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical structure. It...
NabiximolsIn Canada, Sativex has received a Notice of Compliance (NOC) for use as an as adjunctive treatment for symptomatic relief of spasticity in patients with multiple sclerosis (MS) who have...
PalmidrolA cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Palmidrol is available for human use as a supplement (400 mg capsules) and as food...
DexanabinolInvestigated for use/treatment in traumatic brain injuries and neurologic disorders.
GW842166GW842166X has been used in trials studying the treatment of Pain, Analgesia, Inflammation, Osteoarthritis, and Pain, Inflammatory, among others.
SLV319Investigated for use/treatment in obesity.
CannabinolCannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
TaranabantInvestigated for use/treatment in obesity.
OtenabantOtenabant has been investigated for the treatment of Obesity.
Oleic monoethanolamideNot Available
Drugs & Drug Targets
DrugTargetType
DronabinolCannabinoid receptor 1target
DronabinolCytochrome P450 3A4enzyme
DronabinolCytochrome P450 2C9enzyme
DronabinolCannabinoid receptor 2target
DronabinolP-glycoprotein 1transporter
DronabinolATP-binding cassette sub-family G member 2transporter
DronabinolProstaglandin G/H synthase 1enzyme
NabiloneCannabinoid receptor 2target
NabiloneCannabinoid receptor 1target
NabiloneCytochrome P450 2E1enzyme
NabiloneCytochrome P450 2C8enzyme
NabiloneCytochrome P450 2C9enzyme
RimonabantCannabinoid receptor 1target
RimonabantCytochrome P450 3A4enzyme
RimonabantG-protein coupled receptor 55target
CannabidiolCytochrome P450 2C9enzyme
CannabidiolCytochrome P450 2C19enzyme
CannabidiolCytochrome P450 2D6enzyme
CannabidiolCytochrome P450 3A4enzyme
CannabidiolCannabinoid receptor 1target
CannabidiolCannabinoid receptor 2target
CannabidiolG-protein coupled receptor 12target
CannabidiolGlycine receptor subunit alpha-1target
CannabidiolGlycine receptor (alpha-1/beta)target
CannabidiolGlycine receptor subunit alpha-3target
CannabidiolN-arachidonyl glycine receptortarget
CannabidiolG-protein coupled receptor 55target
Cannabidiol5-hydroxytryptamine receptor 1Atarget
Cannabidiol5-hydroxytryptamine receptor 2Atarget
CannabidiolNeuronal acetylcholine receptor subunit alpha-7target
CannabidiolDelta-type opioid receptortarget
CannabidiolMu-type opioid receptortarget
CannabidiolPeroxisome proliferator-activated receptor gammatarget
CannabidiolCytochrome P450 3A5enzyme
CannabidiolArylalkylamine N-acetyltransferaseenzyme
CannabidiolCytochrome P450 1A1enzyme
CannabidiolFatty-acid amide hydrolase 1enzyme
CannabidiolArachidonate 5-lipoxygenaseenzyme
CannabidiolArachidonate 15-lipoxygenaseenzyme
CannabidiolQuinone oxidoreductaseenzyme
CannabidiolMultidrug resistance-associated protein 1transporter
CannabidiolATP-binding cassette sub-family G member 2transporter
CannabidiolEquilibrative nucleoside transporter 1transporter
CannabidiolTransient receptor potential cation channel subfamily V member 1target
CannabidiolVoltage-dependent T-type calcium channel subunit alpha-1Gtarget
CannabidiolVoltage-dependent T-type calcium channel subunit alpha-1Htarget
CannabidiolVoltage-dependent T-type calcium channel subunit alpha-1Itarget
CannabidiolTransient receptor potential cation channel subfamily A member 1target
CannabidiolTransient receptor potential cation channel subfamily M member 8target
CannabidiolTransient receptor potential cation channel subfamily V member 2target
CannabidiolTransient receptor potential cation channel subfamily V member 3target
CannabidiolTransient receptor potential cation channel subfamily V member 4target
CannabidiolVoltage-dependent anion-selective channel protein 1target
Cannabidiol5-hydroxytryptamine receptor 3Atarget
CannabidiolAdenosine receptor A1target
CannabidiolProstaglandin G/H synthase 1target
CannabidiolProstaglandin G/H synthase 2target
CannabidiolAcetyl-CoA acetyltransferase, mitochondrialtarget
CannabidiolSteroid 17-alpha-hydroxylase/17,20 lyasetarget
Cannabidiol3-hydroxy-3-methylglutaryl-coenzyme A reductasetarget
CannabidiolGlutathione reductase, mitochondrialtarget
CannabidiolGlutathione peroxidase 1target
CannabidiolIndoleamine 2,3-dioxygenase 1target
CannabidiolCytochrome P450 1B1target
CannabidiolNAD(P)H dehydrogenase [quinone] 1target
CannabidiolCatalasetarget
CannabidiolCytochrome P450 3A5target
CannabidiolCytochrome P450 2D6target
CannabidiolSuperoxide dismutase [Cu-Zn]target
CannabidiolCytochrome P450 1A2target
CannabidiolCytochrome P450 3A7target
CannabidiolArylalkylamine N-acetyltransferasetarget
CannabidiolN-acylethanolamine-hydrolyzing acid amidasetarget
WIN 55212-2Cytochrome P450 3A4enzyme
NabiximolsCannabinoid receptor 1target
NabiximolsCannabinoid receptor 2target
NabiximolsG-protein coupled receptor 12target
NabiximolsCytochrome P450 2C9enzyme
NabiximolsCytochrome P450 2C19enzyme
NabiximolsCytochrome P450 2D6enzyme
NabiximolsCytochrome P450 3A4enzyme
NabiximolsGlycine receptor subunit alpha-1target
NabiximolsGlycine receptor (alpha-1/beta)target
NabiximolsGlycine receptor subunit alpha-3target
NabiximolsN-arachidonyl glycine receptortarget
NabiximolsG-protein coupled receptor 55target
Nabiximols5-hydroxytryptamine receptor 1Atarget
Nabiximols5-hydroxytryptamine receptor 2Atarget
NabiximolsNeuronal acetylcholine receptor subunit alpha-7target
NabiximolsDelta-type opioid receptortarget
NabiximolsMu-type opioid receptortarget
NabiximolsPeroxisome proliferator-activated receptor gammatarget
NabiximolsCytochrome P450 3A5enzyme
NabiximolsArachidonate 5-lipoxygenaseenzyme
NabiximolsArachidonate 15-lipoxygenaseenzyme
NabiximolsMultidrug resistance-associated protein 1transporter
NabiximolsATP-binding cassette sub-family G member 2transporter
NabiximolsEquilibrative nucleoside transporter 1transporter
NabiximolsTransient receptor potential cation channel subfamily V member 1target
NabiximolsVoltage-dependent T-type calcium channel subunit alpha-1Gtarget
NabiximolsVoltage-dependent T-type calcium channel subunit alpha-1Htarget
NabiximolsVoltage-dependent T-type calcium channel subunit alpha-1Itarget
NabiximolsTransient receptor potential cation channel subfamily A member 1target
NabiximolsTransient receptor potential cation channel subfamily M member 8target
NabiximolsTransient receptor potential cation channel subfamily V member 2target
NabiximolsTransient receptor potential cation channel subfamily V member 3target
NabiximolsTransient receptor potential cation channel subfamily V member 4target
NabiximolsVoltage-dependent anion-selective channel protein 1target
NabiximolsProstaglandin G/H synthase 1target
NabiximolsProstaglandin G/H synthase 2target
NabiximolsAcetyl-CoA acetyltransferase, mitochondrialtarget
NabiximolsSteroid 17-alpha-hydroxylase/17,20 lyasetarget
Nabiximols3-hydroxy-3-methylglutaryl-coenzyme A reductasetarget
NabiximolsGlutathione reductase, mitochondrialtarget
NabiximolsGlutathione peroxidase 1target
NabiximolsIndoleamine 2,3-dioxygenase 1target
NabiximolsArylalkylamine N-acetyltransferasetarget
NabiximolsCytochrome P450 1B1target
NabiximolsCytochrome P450 3A5target
NabiximolsCytochrome P450 2D6target
NabiximolsCytochrome P450 1A2target
NabiximolsCytochrome P450 1A1target
NabiximolsCytochrome P450 3A7target
NabiximolsQuinone oxidoreductasetarget
NabiximolsCatalasetarget
NabiximolsFatty-acid amide hydrolase 1target
NabiximolsSuperoxide dismutase [Cu-Zn]target
NabiximolsN-acylethanolamine-hydrolyzing acid amidasetarget
DexanabinolTumor necrosis factortarget
SLV319Cannabinoid receptor 1target
OtenabantCannabinoid receptor 1target